Availability of Medicines at JAKs

Why in news

The article details the number of Jan Aushadhi Kendras (JAKs) opened across India and in specific constituencies, highlighting the availability and affordability of medicines under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) scheme, along with quality control measures.

Exam relevance

GS2, GS3 · Governance, Economy, Society · Prelims · Mains

Key facts

1. As of 30.06.2026, a total of 20,149 Jan Aushadhi Kendras (JAKs) have been opened across India.
2. Tamil Nadu has 1631 JAKs, with 74 in the Kallakurichi Lok Sabha Constituency (62 in Salem and 12 in Kallakurichi district).
3. The PMBJP product basket includes 2,110 medicines and 315 surgicals, medical consumables, and devices.
4. Medicines under PMBJP are approximately 50% to 80% cheaper than branded medicines.
5. Quality control measures include supplying only from WHO-GMP certified plants and 100% pre-testing of all medicine batches.
6. Random testing of 100% batches is conducted at PMBI's warehouses.

Prelims pointers

• Total JAKs opened nationwide by 30.06.2026: 20,149.
• Product basket includes 2,110 medicines and 315 surgicals/devices.
• Medicines are 50-80% cheaper than branded alternatives.
• Quality assurance: WHO-GMP certification and 100% pre-testing of batches.

Mains practice question

Discuss the significance of the Pradhan Mantri Bhartiya Janaushadhi Pariyojana in ensuring affordable and accessible healthcare in India. What are the key quality assurance mechanisms in place to maintain the efficacy of medicines sold through Jan Aushadhi Kendras?

Static linkage

Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) is a scheme aimed at providing quality generic medicines at affordable prices to the masses through specialized outlets known as Jan Aushadhi Kendras (JAKs). It is part of the government's initiative to reduce out-of-pocket expenditure on medicines and ensure access to essential healthcare.

Significance

The availability of affordable medicines through JAKs significantly reduces healthcare costs for citizens, particularly the economically weaker sections. The scheme promotes the use of generic medicines, thereby increasing accessibility and affordability of healthcare. Stringent quality control measures ensure that the cheaper medicines are also of high quality, safeguarding public health. The expansion of JAKs across the country reflects a commitment to equitable healthcare access.